synthetic cyclic AMP derivatives (Immune Modulation)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namesynthetic cyclic AMP derivatives (Immune Modulation)
Drug Alias Namesynthetic cyclic AMP derivatives (Paraquest)HE-33
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathelicidin antimicrobial peptide modulators
TargetsCathelicidin antimicrobial peptide
Therapy Area/IndicationsGraft vs Host DiseaseLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Modulation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Modulation
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A